June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Area under the Curve as an Alternative Outcome Measure of Dark Adaptation Response
Author Affiliations & Notes
  • Shrinivas Pundlik
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Archana Nigalye
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Ines Lains
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Kevin Mendez
    Brigham and Women's Hospital Channing Division of Network Medicine, Boston, Massachusetts, United States
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
  • Raviv Katz
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Janice Kim
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Vivian P Douglas
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Anna Marmalidou
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Ivana K Kim
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • John Miller
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Demetrios G. Vavvas
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Joan W Miller
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Deeba Husain
    Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Gang Luo
    Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, Massachusetts, United States
    Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts, United States
  • Footnotes
    Commercial Relationships   Shrinivas Pundlik, EyeNexo, LLC (I), Mass Eye & Ear (P); Archana Nigalye, None; Ines Lains, None; Kevin Mendez, None; Raviv Katz, None; Janice Kim, None; Vivian Douglas, None; Anna Marmalidou, None; Ivana Kim, None; John Miller, None; Demetrios Vavvas, None; Joan Miller, None; Deeba Husain, None; Gang Luo, EyeNexo, LLC (I), Mass Eye & Ear (P)
  • Footnotes
    Support  NIH grant EY029847, the Miller Retina Research Fund (Mass. Eye and Ear), the Champalimaud Vision Award, the unrestricted departmental Grant from Research to Prevent Blindness, Inc. New York, and the Commonwealth Unrestricted Grant for Eye Research.
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 279. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Shrinivas Pundlik, Archana Nigalye, Ines Lains, Kevin Mendez, Raviv Katz, Janice Kim, Vivian P Douglas, Anna Marmalidou, Ivana K Kim, John Miller, Demetrios G. Vavvas, Joan W Miller, Deeba Husain, Gang Luo; Area under the Curve as an Alternative Outcome Measure of Dark Adaptation Response. Invest. Ophthalmol. Vis. Sci. 2021;62(8):279.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Rod intercept time (RIT) is commonly used as a measure of dark adaptation (DA) response. However, in some age-related macular degeneration (AMD) patients, the sensitivity fails to recover to the requisite threshold within the testing duration for a valid RIT determination. This precludes proper quantification of the DA response. We evaluated whether DA response in such eyes can be quantified using the area under the dark adaptation curve (AUDAC), which can serve as an alternative measure of DA response within the same testing time frame.

Methods : DA was measured using the AdaptDx (Maculogix, Harrisburg PA) 20-minute protocol (which output RIT value) in 136 eyes (AMD: 98, Control: 38). The RIT criterion was 3 log units sensitivity recovery, failing which, the RIT was set at maximum of 20 minutes per protocol. Separately, normalized AUDAC was computed from the DA curve using the trapezoid method with respect to the same measurement limits. Association between AUDAC and RIT in eyes with RIT < 20 minutes was computed using a linear model, which was then used to predict the RIT values in eyes that failed to record a valid RIT value. Furthermore, the AUDAC was evaluated for predicting AMD presence using a logistic regression model, and the accuracy and the F score were compared with that for the AdaptDx threshold (RIT=6.5 min.).

Results : In 101 eyes with RIT < 20 minutes, the median [IQR] values of RIT and AUDAC were 5.8 [6.4] minutes and 0.063 [0.054], respectively, with a strong linear association between the two measures (p < 0.001, R2 = 0.87). In 35 eyes that failed to record a valid RIT (RIT set at 20 minutes; 34 AMD, 1 control), there was a large variation in the AUDAC (median [IQR]: 0.276 [0.091]) due to the differences in the underlying DA curves, indicating that DA response can still be measured in these eyes. As expected, the RIT was projected to be >20 minutes in 33 out of the 35 eyes (median [IQR] RIT was 24.1 [7.8] minutes) using the linear model between RIT and AUDAC. When predicting AMD presence, the performance of AUDAC (76.5% accuracy; F1=0.84) was comparable to RIT (78% accuracy; F1=0.83).

Conclusions : In eyes where sensitivity fails to recover to the requisite criterion, including many AMD patients, the DA response cannot be quantified using RIT. AUDAC offers a reliable alternative analytic approach to measuring DA response for all eyes, even those that fail to record a valid RIT value.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×